Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)

Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the increase in cancer incidence. The high costs of new...

Full description

Saved in:
Bibliographic Details
Published inSaudi pharmaceutical journal Vol. 29; no. 2; pp. 115 - 120
Main Authors Alkhudair, Nora, Alshamrani, Majed, Samarkandi, Hadeel, Almodaheem, Hajer, Alabdulkarim, Hana, Alsaqaaby, Mai, Alnajjar, Fouad, Alhashem, Hashem, Bakkar, Mohammed, Bazarbashi, Shouki, Alnahedh, Mohammed, Alfraih, Feras, Alawagi, Mohammad, Al-jedai, Ahmed
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier B.V 01.02.2021
Elsevier
Subjects
Cancer
Clinical pharmacy
Economics
Oncology
Original
Pharmacoeconomics
Pharmacy
Saudi
Economics
Saudi
Pharmacy
Clinical pharmacy
Pharmacoeconomics
Oncology
Cancer
Online AccessGet full text

Cover

More Information
Summary:Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the increase in cancer incidence. The high costs of new oncology medications in combination with uncertainty of long-term effectiveness and safety outcomes highlight the importance of considering value, in terms of clinical outcomes, relative to cost. We convened a group of experts to discuss key factors impacting the current state of cancer management in Saudi Arabia and to agree on a list of recommendations, with a focus on value-based care, considering evidence, patients, and costs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1319-0164
2213-7475
DOI:10.1016/j.jsps.2020.12.005